Newton-Bishop J - Search Results

1

Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines.

Vuong K, Armstrong BK, Drummond M, Hopper JL, Barrett JH, Davies JR, Bishop DT, Newton-Bishop J, Aitken JF, Giles GG, Schmid H, Jenkins MA, Mann GJ, McGeechan K, Cust AE. Vuong K, et al. Br J Dermatol. 2020 May;182(5):1262-1268. doi: 10.1111/bjd.18411. Epub 2019 Sep 22. Br J Dermatol. 2020. PMID: 31378928 Free PMC article.

2

Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype.

Newton Bishop JA, Bataille V, Pinney E, Bishop DT. Newton Bishop JA, et al. Melanoma Res. 1994 Aug;4(4):199-206. doi: 10.1097/00008390-199408000-00001. Melanoma Res. 1994. PMID: 7950355

3

Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia.

Grulich AE, Bataille V, Swerdlow AJ, Newton-Bishop JA, Cuzick J, Hersey P, McCarthy WH. Grulich AE, et al. Int J Cancer. 1996 Aug 7;67(4):485-91. doi: 10.1002/(SICI)1097-0215(19960807)67:4<485::AID-IJC4>3.0.CO;2-O. Int J Cancer. 1996. PMID: 8759605 Free article.

4

The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia.

Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton Bishop J, McCarthy W, Hersey P, Cuzick J. Bataille V, et al. Br J Cancer. 1998;77(3):505-10. doi: 10.1038/bjc.1998.81. Br J Cancer. 1998. PMID: 9472652 Free PMC article.

5

The genetics of melanoma: the UK experience.

Newton Bishop JA, Harland M, Bishop DT. Newton Bishop JA, et al. Clin Exp Dermatol. 1998 Jul;23(4):158-61. doi: 10.1046/j.1365-2230.1998.00344.x. Clin Exp Dermatol. 1998. PMID: 9894359 Review.

6

Mutation testing in melanoma families: INK4A, CDK4 and INK4D.

Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT. Newton Bishop JA, et al. Br J Cancer. 1999 Apr;80(1-2):295-300. doi: 10.1038/sj.bjc.6690354. Br J Cancer. 1999. PMID: 10390011 Free PMC article.

7

Mutation screening of the CDKN2A promoter in melanoma families.

Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarrà G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J. Harland M, et al. Genes Chromosomes Cancer. 2000 May;28(1):45-57. Genes Chromosomes Cancer. 2000. PMID: 10738302

8

Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study.

Wachsmuth RC, Gaut RM, Barrett JH, Saunders CL, Randerson-Moor JA, Eldridge A, Martin NG, Bishop TD, Newton Bishop JA. Wachsmuth RC, et al. J Invest Dermatol. 2001 Aug;117(2):348-52. doi: 10.1046/j.0022-202x.2001.01415.x. J Invest Dermatol. 2001. PMID: 11511314 Free article.

9

U.K. guidelines for the management of cutaneous melanoma.

Roberts DL, Anstey AV, Barlow RJ, Cox NH, Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN, Kirkham N; British Association of Dermatologists; Melanoma Study Group. Roberts DL, et al. Br J Dermatol. 2002 Jan;146(1):7-17. doi: 10.1046/j.1365-2133.2001.04614.x. Br J Dermatol. 2002. PMID: 11841361

10

An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.

Bertram CG, Gaut RM, Barrett JH, Pinney E, Whitaker L, Turner F, Bataille V, Dos Santos Silva I, J Swerdlow A, Bishop DT, Newton Bishop JA. Bertram CG, et al. J Invest Dermatol. 2002 Oct;119(4):961-5. doi: 10.1046/j.1523-1747.2002.01825.x. J Invest Dermatol. 2002. PMID: 12406345 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page